Grassley puts Synthes in hot seat over Prodisc
This article was originally published in Clinica
Executive Summary
Swiss orthopaedic firm Synthes has come under the scrutiny of US Senator Charles Grassley as part of the congressman's current inquiries into the financial relationship between doctors and medical device manufacturers (see this issue, pp 10-11).